Goldman Sachs
ETRM

Goldman Sachs’s EnteroMedics Inc. ETRM Stock Holding History

Goldman Sachs’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-459
Closed -$4K – 7389
2016
Q3 		$4K Sell
459
-7
-2% -$95 ﹤0.01% 6942
2016
Q2 		$9K Sell
466
-72
-13% -$3.3K ﹤0.01% 6880
2016
Q1 		$36K Buy
538
+451
+518% +$36.4K ﹤0.01% 6562
2015
Q4 		$12K Buy
+87
New +$18K ﹤0.01% 6951
2015
Q1 		– Sell
-11
Closed -$16K – 7650
2014
Q4 		$16K Sell
11
-81
-88% -$109K ﹤0.01% 7011
2014
Q3 		$119K Buy
92
+60
+188% +$87.9K ﹤0.01% 6502
2014
Q2 		$53K Buy
32
+8
+33% +$15K ﹤0.01% 6749
2014
Q1 		$46K Buy
+24
New +$56.8K ﹤0.01% 6582
2013
Q4 		– Hold
0
– – – 6630

Other funds holding ETRM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Goldman Sachs's ETRM Position: Q4 2016 in Review

Goldman Sachs sold out of EnteroMedics Inc. (ETRM) in Q4 2016, closing a stake of 459 shares — an estimated $4K sold.

Goldman Sachs first reported a position in ETRM in Q1 2014 and held it in 8 quarters. The position peaked at $119K in Q3 2014. 18 funds tracked by Wall St. Rank hold ETRM as of Q4 2016.

  • Goldman Sachs reported no remaining EnteroMedics Inc. position as of Q4 2016 after selling out during the quarter.
  • Goldman Sachs sold 459 EnteroMedics Inc. shares in Q4 2016, an estimated $4K.
  • Goldman Sachs first reported a position in EnteroMedics Inc. in Q1 2014 and held it in 8 quarters.
  • Goldman Sachs's EnteroMedics Inc. position peaked at $119K in Q3 2014.
  • 18 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2016.

Based on Goldman Sachs's 13F filing for Q4 2016, filed 14 Feb 2017.